Who should treat liver transplant patients? The transplant hepatologist or the gastroenterologist? Part I: The Transplant Hepatologist (Englisch)
- Neue Suche nach: Gaglio, P. J.
- Neue Suche nach: Brown, R. S.
- Neue Suche nach: Gaglio, P. J.
- Neue Suche nach: Brown, R. S.
In:
JOURNAL OF HEPATOLOGY
;
44
, 4
;
655-657
;
2006
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Who should treat liver transplant patients? The transplant hepatologist or the gastroenterologist? Part I: The Transplant Hepatologist
-
Beteiligte:Gaglio, P. J. ( Autor:in ) / Brown, R. S. ( Autor:in )
-
Erschienen in:JOURNAL OF HEPATOLOGY ; 44, 4 ; 655-657
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam.
-
Erscheinungsdatum:01.01.2006
-
Format / Umfang:3 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.3623
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.3623 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 44, Ausgabe 4
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 623
-
EASL: A growing association in the global worldPawlotsky, J. M. / EASL, S. S. et al. | 2006
- 624
-
HCV therapy in 2006: Down with ALT levels, in with awareness of co-existent metabolic syndromeHarrison, S. A. et al. | 2006
- 627
-
Immunosuppression and outcomes of patients transplanted for hepatitis CLake, J. R. et al. | 2006
- 630
-
Staging systems for hepatocellular carcinoma: Should we all use the BCLC system?Marrero, J. A. et al. | 2006
- 633
-
Steroids or cocktails for alcoholic hepatitisOShea, R. / McCullough, A. J. et al. | 2006
- 637
-
Sixth Forum on Liver Transplantation. Center approach to liver diseases. Is it worthwhile?Clavien, P. A. et al. | 2006
- 639
-
Do we need a center approach to treat patients with liver diseases?Clavien, P. A. / Mullhaupt, B. / Pestalozzi, B. C. et al. | 2006
- 642
-
Does a liver center make sense from a cost perspective?Delco, F. / Muller, M. J. et al. | 2006
- 647
-
Who should perform liver transplantation? Should that be the transplant surgeon, the hepatobilary surgeon, or the general surgeon?Desai, D. M. / Kuo, P. C. et al. | 2006
- 649
-
Part II: The Hepatobiliary SurgeonBelghiti, J. et al. | 2006
- 652
-
Part III: The General SurgeonSenninger, N. et al. | 2006
- 655
-
Who should treat liver transplant patients? The transplant hepatologist or the gastroenterologist? Part I: The Transplant HepatologistGaglio, P. J. / Brown, R. S. et al. | 2006
- 657
-
Part II: The GastroenterologistMartin, P. et al. | 2006
- 659
-
What impact does a specialized center for transplantation and heptobiliary disease have on post-graduate resident training of gastroenterologists and surgeons?Tuttle-Newhall, J. E. / Diehl, A. M. et al. | 2006
- 663
-
Inhibition of multiple gene expression and virus replication of HBV by stable RNA interference in 2.2.15 cellsRen, X. / Luo, G. / Xie, Z. / Zhou, L. / Kong, X. / Xu, A. et al. | 2006
- 671
-
A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patientsBain, V. G. / Kaita, K. D. / Yoshida, E. M. / Swain, M. G. / Heathcote, E. J. / Neumann, A. U. / Fiscella, M. / Yu, R. / Osborn, B. L. / Cronin, P. W. et al. | 2006
- 679
-
Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis CPrati, D. / Shiffman, M. L. / Diago, M. / Gane, E. / Rajender Reddy, K. / Pockros, P. / Farci, P. / OBrien, C. B. / Lardelli, P. / Blotner, S. et al. | 2006
- 686
-
Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis CSebastiani, G. / Vario, A. / Guido, M. / Noventa, F. / Plebani, M. / Pistis, R. / Ferrari, A. / Alberti, A. et al. | 2006
- 694
-
Mouse livers with macrosteatosis are more susceptible to normothermic ischemic injury than those with microsteatosisSelzner, N. / Selzner, M. / Jochum, W. / Amann-Vesti, B. / Graf, R. / Clavien, P. A. et al. | 2006
- 702
-
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrenceTisone, G. / Orlando, G. / Cardillo, A. / Palmieri, G. / Manzia, T. M. / Baiocchi, L. / Lionetti, R. / Anselmo, A. / Toti, L. / Angelico, M. et al. | 2006
- 710
-
Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: Results from a prospective multicenter randomized studyLlado, L. / Xiol, X. / Figueras, J. / Ramos, E. / Memba, R. / Serrano, T. / Torras, J. / Garcia-Gil, A. / Gonzalez-Pinto, I. / Castellote, J. et al. | 2006
- 717
-
Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppressionBerenguer, M. / Aguilera, V. / Prieto, M. / San Juan, F. / Rayon, J. M. / Benlloch, S. / Berenguer, J. et al. | 2006
- 723
-
Prospective validation of the Barcelona Clinic Liver Cancer staging systemCillo, U. / Vitale, A. / Grigoletto, F. / Farinati, F. / Brolese, A. / Zanus, G. / Neri, D. / Boccagni, P. / Srsen, N. / DAmico, F. et al. | 2006
- 732
-
Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibratesShiri-Sverdlov, R. / Wouters, K. / Gorp, P. J. / Gijbels, M. J. / Noel, B. / Buffat, L. / Staels, B. / Maeda, N. / Bilsen, M. v. / Hofker, M. H. et al. | 2006
- 742
-
Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured ratsOyagi, S. / Hirose, M. / Kojima, M. / Okuyama, M. / Kawase, M. / Nakamura, T. / Ohgushi, H. / Yagi, K. et al. | 2006
- 749
-
Growth and differentiation of colony-forming human hepatocytes in vitroYamasaki, C. / Tateno, C. / Aratani, A. / Ohnishi, C. / Katayama, S. / Kohashi, T. / Hino, H. / Marusawa, H. / Asahara, T. / Yoshizato, K. et al. | 2006
- 758
-
Eve-3: A liver enriched suppressor of Ras/MAPK signalingKing, J. A. / Corcoran, N. M. / DAbaco, G. M. / Straffon, A. F. / Smith, C. T. / Poon, C. L. / Buchert, M. / I, S. / Hall, N. E. / Lock, P. et al. | 2006
- 768
-
Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronidesZelcer, N. / Wetering, K. v. / Waart, R. d. / Scheffer, G. L. / Marschall, H. U. / Wielinga, P. R. / Kuil, A. / Kunne, C. / Smith, A. / Valk, M. v. et al. | 2006
- 776
-
Characterisation of the associations and impact of symptoms in primary biliary cirrhosis using a disease specific quality of life measureNewton, J. L. / Bhala, N. / Burt, J. / Jones, D. E. et al. | 2006
- 784
-
Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis-A randomised clinical trialPhillips, M. / Curtis, H. / Portmann, B. / Donaldson, N. / Bomford, A. / OGrady, J. et al. | 2006
- 791
-
Clinical characteristics and prognostic markers in disulfiram-induced liver injuryBjornsson, E. / Nordlinder, H. / Olsson, R. et al. | 2006
- 798
-
Molecular prognostication of liver cancer: End of the beginningThorgeirsson, S. S. / Lee, J. S. / Grisham, J. W. et al. | 2006
- 806
-
Ischemic cholangiopathyDeltenre, P. / Valla, D. C. et al. | 2006
- 818
-
Occult HBV infection and blood transfusionPrati, D. / Gerosa, A. / Porretti, L. et al. | 2006
- 819
-
In type 1 autoimmune hepatitis (AIH), should remission be redefined as normalization of transaminases?Verma, S. et al. | 2006
- 819
-
ReplyLiu, C. J. / Chen, P. J. / Chen, D. S. et al. | 2006
- 821
-
6-Thioguanine-related hepatotoxicity in patients with inflammatory bowel disease: Dose or level dependent?Derijks, L. J. / Gilissen, L. P. / de Boer, N. K. / Mulder, C. J. et al. | 2006
- 822
-
Length versus width in liver biopsiesCholongitas, E. / Quaglia, A. / Dhillon, A. P. / Patch, D. / Burroughs, A. K. et al. | 2006
- 823
-
Clinical practice and ideal liver biopsy sampling standards:Not just a matter of centimetersGuido, M. / Colloredo, G. / Fassan, M. / Rugge, M. et al. | 2006
- 825
-
The clinical impact of a 24-week treatment course of peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremiaRumi, M. G. / DAmbrosio, R. / Aghemo, A. et al. | 2006
- 827
-
Acute hepatitis due to Mycoplasma pneumoniae infection without lung involvement in adult patientsRomero-Gomez, M. / Otero, M. c. / Sanchez-Munoz, D. / Ramirez-Arcos, M. / Larraona, J. L. / Suarez Garcia, E. / Vargas-Romero, J. et al. | 2006
- 829
-
Liver transplantation in an adult with sclerosing cholangitis due to Langerhans cell histiocytosisGriffiths, W. / Davies, S. / Gibbs, P. / Thillainayagam, A. / Alexander, G. et al. | 2006
- 832
-
Angiopoietin-like proteins: Another player in the metabolic fieldGeorge, J. et al. | 2006
- 835
-
Corrigendum to "Resistance to adefovir: A new challenge in the treatment of chronic hepatitis B" [J Hepatol 43 (2005) 920-923]Marcellin, P. / Asselah, T. et al. | 2006
- 836
-
Announcements| 2006
-
41st Annual Meeting of EASL| 2006
-
Editorial Board| 2006
-
Become Part of Our Vision!| 2006
-
EASL School of Hepatology| 2006